Promising phase III topline results for RBP-6000 monthly depot to treat opioid use disorder Aug. 17, 2016 No Comments
Embera Neurotherapeutics receives grant to continue development of drug for cocaine addition July 27, 2016 No Comments
FDA awards fast track designation to Indivior's RBP-6000 buprenorphine monthly depot May 27, 2016 No Comments
RSS